According to Grand View Research, specifically for GLP-1 weight-loss, the market size in 2025 is about $20.86 billion, expected to grow to $48.84 billion by 2030, with a CAGR of ~18.5%
Rhodes explains in this video, GLP-1 medications work by mimicking a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which plays a key role in regulating both appetite and blood sugar
This effect might be due to direct enterocyte injury by SARS-CoV-2 or indirectly due to hyperinflammation and cytokine storm (Jung and Jung 2022)
Among them, liraglutide has proven to be one of the most commonly prescribed pharmacotherapy for treating obesity, due in large part to the pronounced weight loss and relatively modest profile of adverse events 21,22,53
IV therapy is a medical treatment that includes the injection of fluids, essential vitamins, much-needed minerals, and other important nutrients straight into your bloodstream with the use of an intravenous line